nodes	percent_of_prediction	percent_of_DWPC	metapath
Nabilone—CNR2—hematologic cancer	0.677	1	CbGaD
Nabilone—CNR2—hematopoietic system—hematologic cancer	0.0104	0.367	CbGeAlD
Nabilone—CNR2—blood—hematologic cancer	0.00687	0.243	CbGeAlD
Nabilone—CNR1—lung—hematologic cancer	0.00419	0.148	CbGeAlD
Nabilone—Dronabinol—CNR2—hematologic cancer	0.00396	0.72	CrCbGaD
Nabilone—CNR1—testis—hematologic cancer	0.00395	0.14	CbGeAlD
Nabilone—CNR1—lymph node—hematologic cancer	0.00287	0.101	CbGeAlD
Nabilone—Dronabinol—ABCG2—hematologic cancer	0.00109	0.198	CrCbGaD
Nabilone—Dronabinol—ABCB1—hematologic cancer	0.000452	0.0823	CrCbGaD
Nabilone—CNR2—Signaling Pathways—CTNNA1—hematologic cancer	6.38e-05	0.000889	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—AGO2—hematologic cancer	6.35e-05	0.000886	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—SPHK1—hematologic cancer	6.35e-05	0.000886	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—EIF4EBP1—hematologic cancer	6.34e-05	0.000884	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—HSPB1—hematologic cancer	6.34e-05	0.000884	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CCL3—hematologic cancer	6.34e-05	0.000884	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—LPAR1—hematologic cancer	6.29e-05	0.000877	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—HDAC9—hematologic cancer	6.29e-05	0.000877	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—SDC1—hematologic cancer	6.27e-05	0.000874	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PTHLH—hematologic cancer	6.27e-05	0.000874	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—H3F3B—hematologic cancer	6.22e-05	0.000868	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—IL2RA—hematologic cancer	6.17e-05	0.00086	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PTGER4—hematologic cancer	6.1e-05	0.000851	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—LCK—hematologic cancer	6.07e-05	0.000847	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—GRB2—hematologic cancer	6.01e-05	0.000838	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—H3F3A—hematologic cancer	5.95e-05	0.00083	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—CSF2—hematologic cancer	5.91e-05	0.000824	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PRKCZ—hematologic cancer	5.79e-05	0.000807	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CNR2—hematologic cancer	5.79e-05	0.000807	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PDE4B—hematologic cancer	5.79e-05	0.000807	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—FGF19—hematologic cancer	5.74e-05	0.0008	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—JAK1—hematologic cancer	5.7e-05	0.000796	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—PRKCG—hematologic cancer	5.7e-05	0.000796	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—RAC2—hematologic cancer	5.69e-05	0.000794	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—PIK3CG—hematologic cancer	5.66e-05	0.000789	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—DKK1—hematologic cancer	5.65e-05	0.000788	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—STAT5B—hematologic cancer	5.6e-05	0.000782	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PARP1—hematologic cancer	5.59e-05	0.000779	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—FBXW7—hematologic cancer	5.5e-05	0.000767	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—ADCY7—hematologic cancer	5.44e-05	0.000759	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—HDAC2—hematologic cancer	5.39e-05	0.000752	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CXCR4—hematologic cancer	5.39e-05	0.000752	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—CSF2—hematologic cancer	5.37e-05	0.000748	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—IL2RA—hematologic cancer	5.33e-05	0.000743	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—XIAP—hematologic cancer	5.29e-05	0.000738	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CBL—hematologic cancer	5.25e-05	0.000733	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—IL3—hematologic cancer	5.2e-05	0.000725	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—JAK1—hematologic cancer	5.18e-05	0.000722	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—PRKCG—hematologic cancer	5.18e-05	0.000722	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—SH2B3—hematologic cancer	5.16e-05	0.000719	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—SMARCA4—hematologic cancer	5.16e-05	0.000719	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—PIK3CG—hematologic cancer	5.14e-05	0.000716	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—GZMB—hematologic cancer	5.13e-05	0.000715	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PTPN1—hematologic cancer	5.11e-05	0.000713	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—PTPN11—hematologic cancer	5.05e-05	0.000704	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—RASGRP1—hematologic cancer	5.03e-05	0.000701	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—HSP90AA1—hematologic cancer	5.01e-05	0.000699	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—SYK—hematologic cancer	5.01e-05	0.000699	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CTNNA1—hematologic cancer	5.01e-05	0.000698	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—EIF4EBP1—hematologic cancer	4.98e-05	0.000694	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CCL3—hematologic cancer	4.98e-05	0.000694	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—HSPB1—hematologic cancer	4.98e-05	0.000694	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—PIK3CD—hematologic cancer	4.97e-05	0.000693	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PTHLH—hematologic cancer	4.92e-05	0.000686	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—SDC1—hematologic cancer	4.92e-05	0.000686	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—CREB1—hematologic cancer	4.89e-05	0.000682	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—IL2RA—hematologic cancer	4.84e-05	0.000675	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—STAT1—hematologic cancer	4.83e-05	0.000674	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PTGER4—hematologic cancer	4.79e-05	0.000668	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—CCL2—hematologic cancer	4.78e-05	0.000667	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—IL6R—hematologic cancer	4.77e-05	0.000665	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—LCK—hematologic cancer	4.77e-05	0.000665	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—PIK3R1—hematologic cancer	4.7e-05	0.000655	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—H3F3A—hematologic cancer	4.67e-05	0.000651	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—JAK2—hematologic cancer	4.56e-05	0.000636	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—MAP2K1—hematologic cancer	4.55e-05	0.000634	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PRKCZ—hematologic cancer	4.54e-05	0.000633	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—GRB2—hematologic cancer	4.52e-05	0.000631	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—PIK3CD—hematologic cancer	4.52e-05	0.00063	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PDGFA—hematologic cancer	4.51e-05	0.000629	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—KITLG—hematologic cancer	4.45e-05	0.00062	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—PIK3CG—hematologic cancer	4.44e-05	0.000619	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PARP1—hematologic cancer	4.39e-05	0.000612	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—STAT5A—hematologic cancer	4.35e-05	0.000606	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—PIK3CB—hematologic cancer	4.33e-05	0.000604	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—FBXW7—hematologic cancer	4.31e-05	0.000602	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CDKN2B—hematologic cancer	4.31e-05	0.000601	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—PIK3R1—hematologic cancer	4.26e-05	0.000595	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CXCR4—hematologic cancer	4.23e-05	0.00059	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—HDAC2—hematologic cancer	4.23e-05	0.00059	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CD86—hematologic cancer	4.17e-05	0.000581	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—JAK2—hematologic cancer	4.14e-05	0.000578	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CBL—hematologic cancer	4.12e-05	0.000575	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—HES1—hematologic cancer	4.11e-05	0.000573	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—NCOR1—hematologic cancer	4.09e-05	0.00057	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—IL3—hematologic cancer	4.08e-05	0.000569	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CSF2—hematologic cancer	4.04e-05	0.000563	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—FGF1—hematologic cancer	4.04e-05	0.000563	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—PIK3CG—hematologic cancer	4.03e-05	0.000562	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PTPN1—hematologic cancer	4.01e-05	0.000559	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—FOXO1—hematologic cancer	3.98e-05	0.000555	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—IL2—hematologic cancer	3.98e-05	0.000555	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PDGFRB—hematologic cancer	3.98e-05	0.000554	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—PTPN11—hematologic cancer	3.96e-05	0.000552	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—RASGRP1—hematologic cancer	3.95e-05	0.00055	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—PIK3CB—hematologic cancer	3.94e-05	0.000549	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—HSP90AA1—hematologic cancer	3.93e-05	0.000549	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—SYK—hematologic cancer	3.93e-05	0.000549	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PDGFRA—hematologic cancer	3.91e-05	0.000546	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—PIK3CD—hematologic cancer	3.9e-05	0.000544	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—JAK1—hematologic cancer	3.9e-05	0.000544	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PRKCG—hematologic cancer	3.9e-05	0.000544	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—CREB1—hematologic cancer	3.84e-05	0.000535	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—STAT1—hematologic cancer	3.79e-05	0.000529	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—CCL2—hematologic cancer	3.75e-05	0.000524	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—IL6R—hematologic cancer	3.74e-05	0.000522	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—PIK3R1—hematologic cancer	3.68e-05	0.000514	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—IL2RA—hematologic cancer	3.64e-05	0.000508	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—IL2—hematologic cancer	3.61e-05	0.000504	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—TERT—hematologic cancer	3.6e-05	0.000502	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—JAK2—hematologic cancer	3.58e-05	0.000499	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—MAP2K1—hematologic cancer	3.57e-05	0.000497	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—GRB2—hematologic cancer	3.55e-05	0.000495	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—PIK3CD—hematologic cancer	3.54e-05	0.000494	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PDGFA—hematologic cancer	3.54e-05	0.000494	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PDGFB—hematologic cancer	3.52e-05	0.00049	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—KITLG—hematologic cancer	3.49e-05	0.000487	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—TSC2—hematologic cancer	3.44e-05	0.000479	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—STAT5A—hematologic cancer	3.41e-05	0.000476	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—PIK3CB—hematologic cancer	3.4e-05	0.000474	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CDKN2B—hematologic cancer	3.38e-05	0.000471	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—PIK3R1—hematologic cancer	3.35e-05	0.000467	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—FGFR3—hematologic cancer	3.31e-05	0.000461	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—MAPK14—hematologic cancer	3.27e-05	0.000456	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CD86—hematologic cancer	3.27e-05	0.000456	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—JAK2—hematologic cancer	3.25e-05	0.000453	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—HES1—hematologic cancer	3.23e-05	0.00045	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—ESR1—hematologic cancer	3.21e-05	0.000448	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—NCOR1—hematologic cancer	3.21e-05	0.000447	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—FN1—hematologic cancer	3.17e-05	0.000442	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CSF2—hematologic cancer	3.17e-05	0.000442	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—FGF1—hematologic cancer	3.17e-05	0.000442	CbGpPWpGaD
Nabilone—Flushing—Epirubicin—hematologic cancer	3.17e-05	0.000146	CcSEcCtD
Nabilone—Hypersensitivity—Prednisolone—hematologic cancer	3.14e-05	0.000145	CcSEcCtD
Nabilone—Hypoaesthesia—Doxorubicin—hematologic cancer	3.14e-05	0.000145	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—BAD—hematologic cancer	3.13e-05	0.000437	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—NFKBIA—hematologic cancer	3.13e-05	0.000437	CbGpPWpGaD
Nabilone—Pharyngitis—Doxorubicin—hematologic cancer	3.13e-05	0.000144	CcSEcCtD
Nabilone—Dyspepsia—Betamethasone—hematologic cancer	3.13e-05	0.000144	CcSEcCtD
Nabilone—Dyspepsia—Dexamethasone—hematologic cancer	3.13e-05	0.000144	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—FOXO1—hematologic cancer	3.12e-05	0.000436	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—IL2—hematologic cancer	3.12e-05	0.000436	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PDGFRB—hematologic cancer	3.12e-05	0.000435	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—NOTCH1—hematologic cancer	3.1e-05	0.000433	CbGpPWpGaD
Nabilone—Asthenia—Etoposide—hematologic cancer	3.1e-05	0.000143	CcSEcCtD
Nabilone—Body temperature increased—Triamcinolone—hematologic cancer	3.1e-05	0.000143	CcSEcCtD
Nabilone—Decreased appetite—Dexamethasone—hematologic cancer	3.09e-05	0.000142	CcSEcCtD
Nabilone—Decreased appetite—Betamethasone—hematologic cancer	3.09e-05	0.000142	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—PIK3CB—hematologic cancer	3.09e-05	0.000431	CbGpPWpGaD
Nabilone—Nausea—Mitoxantrone—hematologic cancer	3.09e-05	0.000142	CcSEcCtD
Nabilone—Nausea—Irinotecan—hematologic cancer	3.09e-05	0.000142	CcSEcCtD
Nabilone—Infection—Prednisone—hematologic cancer	3.08e-05	0.000142	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—PDGFRA—hematologic cancer	3.07e-05	0.000428	CbGpPWpGaD
Nabilone—Back pain—Methotrexate—hematologic cancer	3.07e-05	0.000141	CcSEcCtD
Nabilone—Fatigue—Betamethasone—hematologic cancer	3.07e-05	0.000141	CcSEcCtD
Nabilone—Fatigue—Dexamethasone—hematologic cancer	3.07e-05	0.000141	CcSEcCtD
Nabilone—Chills—Epirubicin—hematologic cancer	3.06e-05	0.000141	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—PRKCG—hematologic cancer	3.06e-05	0.000427	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—JAK1—hematologic cancer	3.06e-05	0.000427	CbGpPWpGaD
Nabilone—Pruritus—Etoposide—hematologic cancer	3.06e-05	0.000141	CcSEcCtD
Nabilone—Shock—Prednisone—hematologic cancer	3.05e-05	0.00014	CcSEcCtD
Nabilone—Arrhythmia—Epirubicin—hematologic cancer	3.05e-05	0.00014	CcSEcCtD
Nabilone—Pain—Dexamethasone—hematologic cancer	3.04e-05	0.00014	CcSEcCtD
Nabilone—Pain—Betamethasone—hematologic cancer	3.04e-05	0.00014	CcSEcCtD
Nabilone—Visual impairment—Doxorubicin—hematologic cancer	3.04e-05	0.00014	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—CD80—hematologic cancer	3.04e-05	0.000424	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PIK3CG—hematologic cancer	3.03e-05	0.000423	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—KIT—hematologic cancer	3.03e-05	0.000423	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—NRAS—hematologic cancer	3.03e-05	0.000423	CbGpPWpGaD
Nabilone—Tachycardia—Prednisone—hematologic cancer	3.02e-05	0.000139	CcSEcCtD
Nabilone—Nausea—Gemcitabine—hematologic cancer	3.01e-05	0.000138	CcSEcCtD
Nabilone—Vomiting—Cisplatin—hematologic cancer	3e-05	0.000138	CcSEcCtD
Nabilone—Hyperhidrosis—Prednisone—hematologic cancer	3e-05	0.000138	CcSEcCtD
Nabilone—Vision blurred—Methotrexate—hematologic cancer	2.99e-05	0.000138	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—PTPN11—hematologic cancer	2.98e-05	0.000416	CbGpPWpGaD
Nabilone—Rash—Cisplatin—hematologic cancer	2.98e-05	0.000137	CcSEcCtD
Nabilone—Dermatitis—Cisplatin—hematologic cancer	2.97e-05	0.000137	CcSEcCtD
Nabilone—Diarrhoea—Etoposide—hematologic cancer	2.96e-05	0.000136	CcSEcCtD
Nabilone—Anorexia—Prednisone—hematologic cancer	2.95e-05	0.000136	CcSEcCtD
Nabilone—Eye disorder—Doxorubicin—hematologic cancer	2.95e-05	0.000136	CcSEcCtD
Nabilone—Ill-defined disorder—Methotrexate—hematologic cancer	2.94e-05	0.000136	CcSEcCtD
Nabilone—Tinnitus—Doxorubicin—hematologic cancer	2.94e-05	0.000135	CcSEcCtD
Nabilone—Anaemia—Methotrexate—hematologic cancer	2.93e-05	0.000135	CcSEcCtD
Nabilone—Feeling abnormal—Betamethasone—hematologic cancer	2.93e-05	0.000135	CcSEcCtD
Nabilone—Feeling abnormal—Dexamethasone—hematologic cancer	2.93e-05	0.000135	CcSEcCtD
Nabilone—Flushing—Doxorubicin—hematologic cancer	2.93e-05	0.000135	CcSEcCtD
Nabilone—Tension—Epirubicin—hematologic cancer	2.91e-05	0.000134	CcSEcCtD
Nabilone—Gastrointestinal pain—Dexamethasone—hematologic cancer	2.91e-05	0.000134	CcSEcCtD
Nabilone—Gastrointestinal pain—Betamethasone—hematologic cancer	2.91e-05	0.000134	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—MAPK3—hematologic cancer	2.91e-05	0.000405	CbGpPWpGaD
Nabilone—Hypersensitivity—Triamcinolone—hematologic cancer	2.89e-05	0.000133	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—CREB1—hematologic cancer	2.89e-05	0.000403	CbGpPWpGaD
Nabilone—Nervousness—Epirubicin—hematologic cancer	2.88e-05	0.000133	CcSEcCtD
Nabilone—Back pain—Epirubicin—hematologic cancer	2.87e-05	0.000132	CcSEcCtD
Nabilone—Malaise—Methotrexate—hematologic cancer	2.86e-05	0.000132	CcSEcCtD
Nabilone—Dizziness—Etoposide—hematologic cancer	2.86e-05	0.000132	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—IL2RA—hematologic cancer	2.86e-05	0.000399	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—BRAF—hematologic cancer	2.85e-05	0.000398	CbGpPWpGaD
Nabilone—Vertigo—Methotrexate—hematologic cancer	2.85e-05	0.000131	CcSEcCtD
Nabilone—Leukopenia—Methotrexate—hematologic cancer	2.84e-05	0.000131	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—IL2—hematologic cancer	2.84e-05	0.000396	CbGpPWpGaD
Nabilone—Chills—Doxorubicin—hematologic cancer	2.83e-05	0.00013	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—CCL2—hematologic cancer	2.83e-05	0.000394	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—TERT—hematologic cancer	2.83e-05	0.000394	CbGpPWpGaD
Nabilone—Musculoskeletal discomfort—Prednisone—hematologic cancer	2.82e-05	0.00013	CcSEcCtD
Nabilone—Dizziness—Prednisolone—hematologic cancer	2.82e-05	0.00013	CcSEcCtD
Nabilone—Arrhythmia—Doxorubicin—hematologic cancer	2.82e-05	0.00013	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—IL6R—hematologic cancer	2.82e-05	0.000393	CbGpPWpGaD
Nabilone—Asthenia—Triamcinolone—hematologic cancer	2.81e-05	0.00013	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—CREBBP—hematologic cancer	2.81e-05	0.000392	CbGpPWpGaD
Nabilone—Abdominal pain—Betamethasone—hematologic cancer	2.81e-05	0.000129	CcSEcCtD
Nabilone—Abdominal pain—Dexamethasone—hematologic cancer	2.81e-05	0.000129	CcSEcCtD
Nabilone—Body temperature increased—Dexamethasone—hematologic cancer	2.81e-05	0.000129	CcSEcCtD
Nabilone—Body temperature increased—Betamethasone—hematologic cancer	2.81e-05	0.000129	CcSEcCtD
Nabilone—Nausea—Cisplatin—hematologic cancer	2.8e-05	0.000129	CcSEcCtD
Nabilone—Insomnia—Prednisone—hematologic cancer	2.8e-05	0.000129	CcSEcCtD
Nabilone—Vision blurred—Epirubicin—hematologic cancer	2.8e-05	0.000129	CcSEcCtD
Nabilone—Paraesthesia—Prednisone—hematologic cancer	2.78e-05	0.000128	CcSEcCtD
Nabilone—Pruritus—Triamcinolone—hematologic cancer	2.77e-05	0.000128	CcSEcCtD
Nabilone—Cough—Methotrexate—hematologic cancer	2.77e-05	0.000127	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—PDGFB—hematologic cancer	2.76e-05	0.000385	CbGpPWpGaD
Nabilone—Ill-defined disorder—Epirubicin—hematologic cancer	2.76e-05	0.000127	CcSEcCtD
Nabilone—Convulsion—Methotrexate—hematologic cancer	2.75e-05	0.000127	CcSEcCtD
Nabilone—Vomiting—Etoposide—hematologic cancer	2.75e-05	0.000127	CcSEcCtD
Nabilone—Anaemia—Epirubicin—hematologic cancer	2.74e-05	0.000126	CcSEcCtD
Nabilone—Agitation—Epirubicin—hematologic cancer	2.73e-05	0.000126	CcSEcCtD
Nabilone—Dyspepsia—Prednisone—hematologic cancer	2.73e-05	0.000126	CcSEcCtD
Nabilone—Rash—Etoposide—hematologic cancer	2.73e-05	0.000125	CcSEcCtD
Nabilone—Dermatitis—Etoposide—hematologic cancer	2.72e-05	0.000125	CcSEcCtD
Nabilone—Headache—Etoposide—hematologic cancer	2.71e-05	0.000125	CcSEcCtD
Nabilone—Chest pain—Methotrexate—hematologic cancer	2.7e-05	0.000124	CcSEcCtD
Nabilone—Myalgia—Methotrexate—hematologic cancer	2.7e-05	0.000124	CcSEcCtD
Nabilone—Arthralgia—Methotrexate—hematologic cancer	2.7e-05	0.000124	CcSEcCtD
Nabilone—Tension—Doxorubicin—hematologic cancer	2.7e-05	0.000124	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—TSC2—hematologic cancer	2.7e-05	0.000376	CbGpPWpGaD
Nabilone—Decreased appetite—Prednisone—hematologic cancer	2.69e-05	0.000124	CcSEcCtD
Nabilone—Rash—Prednisolone—hematologic cancer	2.69e-05	0.000124	CcSEcCtD
Nabilone—Dermatitis—Prednisolone—hematologic cancer	2.69e-05	0.000124	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—MAP2K1—hematologic cancer	2.69e-05	0.000374	CbGpPWpGaD
Nabilone—Malaise—Epirubicin—hematologic cancer	2.68e-05	0.000123	CcSEcCtD
Nabilone—Fatigue—Prednisone—hematologic cancer	2.67e-05	0.000123	CcSEcCtD
Nabilone—Headache—Prednisolone—hematologic cancer	2.67e-05	0.000123	CcSEcCtD
Nabilone—Discomfort—Methotrexate—hematologic cancer	2.67e-05	0.000123	CcSEcCtD
Nabilone—Nervousness—Doxorubicin—hematologic cancer	2.67e-05	0.000123	CcSEcCtD
Nabilone—Vertigo—Epirubicin—hematologic cancer	2.67e-05	0.000123	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—PIK3CD—hematologic cancer	2.67e-05	0.000372	CbGpPWpGaD
Nabilone—Syncope—Epirubicin—hematologic cancer	2.66e-05	0.000123	CcSEcCtD
Nabilone—Leukopenia—Epirubicin—hematologic cancer	2.66e-05	0.000122	CcSEcCtD
Nabilone—Back pain—Doxorubicin—hematologic cancer	2.66e-05	0.000122	CcSEcCtD
Nabilone—Constipation—Prednisone—hematologic cancer	2.65e-05	0.000122	CcSEcCtD
Nabilone—CNR2—GPCR downstream signaling—PIK3CA—hematologic cancer	2.64e-05	0.000368	CbGpPWpGaD
Nabilone—Palpitations—Epirubicin—hematologic cancer	2.62e-05	0.000121	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—KRAS—hematologic cancer	2.61e-05	0.000364	CbGpPWpGaD
Nabilone—Confusional state—Methotrexate—hematologic cancer	2.61e-05	0.00012	CcSEcCtD
Nabilone—Loss of consciousness—Epirubicin—hematologic cancer	2.61e-05	0.00012	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—FGFR3—hematologic cancer	2.59e-05	0.000362	CbGpPWpGaD
Nabilone—Dizziness—Triamcinolone—hematologic cancer	2.59e-05	0.000119	CcSEcCtD
Nabilone—Cough—Epirubicin—hematologic cancer	2.59e-05	0.000119	CcSEcCtD
Nabilone—Vision blurred—Doxorubicin—hematologic cancer	2.59e-05	0.000119	CcSEcCtD
Nabilone—Convulsion—Epirubicin—hematologic cancer	2.57e-05	0.000118	CcSEcCtD
Nabilone—Infection—Methotrexate—hematologic cancer	2.57e-05	0.000118	CcSEcCtD
Nabilone—Nausea—Etoposide—hematologic cancer	2.57e-05	0.000118	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—MAPK14—hematologic cancer	2.57e-05	0.000358	CbGpPWpGaD
Nabilone—Hypertension—Epirubicin—hematologic cancer	2.56e-05	0.000118	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—FGF2—hematologic cancer	2.55e-05	0.000356	CbGpPWpGaD
Nabilone—Feeling abnormal—Prednisone—hematologic cancer	2.55e-05	0.000118	CcSEcCtD
Nabilone—Asthenia—Dexamethasone—hematologic cancer	2.55e-05	0.000118	CcSEcCtD
Nabilone—Asthenia—Betamethasone—hematologic cancer	2.55e-05	0.000118	CcSEcCtD
Nabilone—Ill-defined disorder—Doxorubicin—hematologic cancer	2.55e-05	0.000117	CcSEcCtD
Nabilone—Anaemia—Doxorubicin—hematologic cancer	2.54e-05	0.000117	CcSEcCtD
Nabilone—Gastrointestinal pain—Prednisone—hematologic cancer	2.53e-05	0.000117	CcSEcCtD
Nabilone—Nausea—Prednisolone—hematologic cancer	2.53e-05	0.000117	CcSEcCtD
Nabilone—Arthralgia—Epirubicin—hematologic cancer	2.53e-05	0.000116	CcSEcCtD
Nabilone—Myalgia—Epirubicin—hematologic cancer	2.53e-05	0.000116	CcSEcCtD
Nabilone—Chest pain—Epirubicin—hematologic cancer	2.53e-05	0.000116	CcSEcCtD
Nabilone—Agitation—Doxorubicin—hematologic cancer	2.52e-05	0.000116	CcSEcCtD
Nabilone—Anxiety—Epirubicin—hematologic cancer	2.52e-05	0.000116	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—PIK3R1—hematologic cancer	2.52e-05	0.000351	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—ESR1—hematologic cancer	2.52e-05	0.000351	CbGpPWpGaD
Nabilone—Pruritus—Betamethasone—hematologic cancer	2.52e-05	0.000116	CcSEcCtD
Nabilone—Pruritus—Dexamethasone—hematologic cancer	2.52e-05	0.000116	CcSEcCtD
Nabilone—Hyperhidrosis—Methotrexate—hematologic cancer	2.5e-05	0.000115	CcSEcCtD
Nabilone—Discomfort—Epirubicin—hematologic cancer	2.5e-05	0.000115	CcSEcCtD
Nabilone—Vomiting—Triamcinolone—hematologic cancer	2.49e-05	0.000115	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—FN1—hematologic cancer	2.49e-05	0.000347	CbGpPWpGaD
Nabilone—Malaise—Doxorubicin—hematologic cancer	2.48e-05	0.000114	CcSEcCtD
Nabilone—Rash—Triamcinolone—hematologic cancer	2.47e-05	0.000114	CcSEcCtD
Nabilone—Dry mouth—Epirubicin—hematologic cancer	2.47e-05	0.000114	CcSEcCtD
Nabilone—Dermatitis—Triamcinolone—hematologic cancer	2.47e-05	0.000114	CcSEcCtD
Nabilone—Vertigo—Doxorubicin—hematologic cancer	2.47e-05	0.000114	CcSEcCtD
Nabilone—Anorexia—Methotrexate—hematologic cancer	2.47e-05	0.000114	CcSEcCtD
Nabilone—Syncope—Doxorubicin—hematologic cancer	2.46e-05	0.000113	CcSEcCtD
Nabilone—Leukopenia—Doxorubicin—hematologic cancer	2.46e-05	0.000113	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—NFKBIA—hematologic cancer	2.46e-05	0.000343	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—BAD—hematologic cancer	2.46e-05	0.000343	CbGpPWpGaD
Nabilone—Headache—Triamcinolone—hematologic cancer	2.46e-05	0.000113	CcSEcCtD
Nabilone—Abdominal pain—Prednisone—hematologic cancer	2.45e-05	0.000113	CcSEcCtD
Nabilone—Body temperature increased—Prednisone—hematologic cancer	2.45e-05	0.000113	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—JAK2—hematologic cancer	2.45e-05	0.000341	CbGpPWpGaD
Nabilone—Confusional state—Epirubicin—hematologic cancer	2.44e-05	0.000112	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—NOTCH1—hematologic cancer	2.43e-05	0.00034	CbGpPWpGaD
Nabilone—Diarrhoea—Betamethasone—hematologic cancer	2.43e-05	0.000112	CcSEcCtD
Nabilone—Diarrhoea—Dexamethasone—hematologic cancer	2.43e-05	0.000112	CcSEcCtD
Nabilone—Palpitations—Doxorubicin—hematologic cancer	2.43e-05	0.000112	CcSEcCtD
Nabilone—Hypotension—Methotrexate—hematologic cancer	2.42e-05	0.000111	CcSEcCtD
Nabilone—Loss of consciousness—Doxorubicin—hematologic cancer	2.41e-05	0.000111	CcSEcCtD
Nabilone—Infection—Epirubicin—hematologic cancer	2.41e-05	0.000111	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—PIK3CA—hematologic cancer	2.4e-05	0.000335	CbGpPWpGaD
Nabilone—Cough—Doxorubicin—hematologic cancer	2.4e-05	0.00011	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—MDM2—hematologic cancer	2.39e-05	0.000333	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CD80—hematologic cancer	2.39e-05	0.000333	CbGpPWpGaD
Nabilone—Shock—Epirubicin—hematologic cancer	2.38e-05	0.00011	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—PIK3CG—hematologic cancer	2.38e-05	0.000332	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—KIT—hematologic cancer	2.38e-05	0.000332	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—NRAS—hematologic cancer	2.38e-05	0.000332	CbGpPWpGaD
Nabilone—Convulsion—Doxorubicin—hematologic cancer	2.38e-05	0.00011	CcSEcCtD
Nabilone—Hypertension—Doxorubicin—hematologic cancer	2.37e-05	0.000109	CcSEcCtD
Nabilone—Tachycardia—Epirubicin—hematologic cancer	2.37e-05	0.000109	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Methotrexate—hematologic cancer	2.36e-05	0.000109	CcSEcCtD
Nabilone—Dizziness—Betamethasone—hematologic cancer	2.35e-05	0.000108	CcSEcCtD
Nabilone—Dizziness—Dexamethasone—hematologic cancer	2.35e-05	0.000108	CcSEcCtD
Nabilone—Hyperhidrosis—Epirubicin—hematologic cancer	2.34e-05	0.000108	CcSEcCtD
Nabilone—Insomnia—Methotrexate—hematologic cancer	2.34e-05	0.000108	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—PTPN11—hematologic cancer	2.34e-05	0.000326	CbGpPWpGaD
Nabilone—Myalgia—Doxorubicin—hematologic cancer	2.34e-05	0.000108	CcSEcCtD
Nabilone—Arthralgia—Doxorubicin—hematologic cancer	2.34e-05	0.000108	CcSEcCtD
Nabilone—Chest pain—Doxorubicin—hematologic cancer	2.34e-05	0.000108	CcSEcCtD
Nabilone—Anxiety—Doxorubicin—hematologic cancer	2.33e-05	0.000107	CcSEcCtD
Nabilone—Nausea—Triamcinolone—hematologic cancer	2.33e-05	0.000107	CcSEcCtD
Nabilone—Paraesthesia—Methotrexate—hematologic cancer	2.33e-05	0.000107	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—MTOR—hematologic cancer	2.33e-05	0.000324	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PIK3CB—hematologic cancer	2.33e-05	0.000324	CbGpPWpGaD
Nabilone—Discomfort—Doxorubicin—hematologic cancer	2.31e-05	0.000106	CcSEcCtD
Nabilone—Anorexia—Epirubicin—hematologic cancer	2.31e-05	0.000106	CcSEcCtD
Nabilone—Dyspnoea—Methotrexate—hematologic cancer	2.31e-05	0.000106	CcSEcCtD
Nabilone—Somnolence—Methotrexate—hematologic cancer	2.3e-05	0.000106	CcSEcCtD
Nabilone—Dry mouth—Doxorubicin—hematologic cancer	2.29e-05	0.000105	CcSEcCtD
Nabilone—Hypersensitivity—Prednisone—hematologic cancer	2.28e-05	0.000105	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—MAPK3—hematologic cancer	2.28e-05	0.000318	CbGpPWpGaD
Nabilone—Dyspepsia—Methotrexate—hematologic cancer	2.28e-05	0.000105	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—CREB1—hematologic cancer	2.27e-05	0.000316	CbGpPWpGaD
Nabilone—Hypotension—Epirubicin—hematologic cancer	2.26e-05	0.000104	CcSEcCtD
Nabilone—Vomiting—Betamethasone—hematologic cancer	2.26e-05	0.000104	CcSEcCtD
Nabilone—Vomiting—Dexamethasone—hematologic cancer	2.26e-05	0.000104	CcSEcCtD
Nabilone—Confusional state—Doxorubicin—hematologic cancer	2.26e-05	0.000104	CcSEcCtD
Nabilone—Decreased appetite—Methotrexate—hematologic cancer	2.25e-05	0.000104	CcSEcCtD
Nabilone—Rash—Betamethasone—hematologic cancer	2.24e-05	0.000103	CcSEcCtD
Nabilone—Rash—Dexamethasone—hematologic cancer	2.24e-05	0.000103	CcSEcCtD
Nabilone—Dermatitis—Dexamethasone—hematologic cancer	2.24e-05	0.000103	CcSEcCtD
Nabilone—Dermatitis—Betamethasone—hematologic cancer	2.24e-05	0.000103	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—BRAF—hematologic cancer	2.24e-05	0.000312	CbGpPWpGaD
Nabilone—Fatigue—Methotrexate—hematologic cancer	2.23e-05	0.000103	CcSEcCtD
Nabilone—Headache—Betamethasone—hematologic cancer	2.23e-05	0.000103	CcSEcCtD
Nabilone—Headache—Dexamethasone—hematologic cancer	2.23e-05	0.000103	CcSEcCtD
Nabilone—Infection—Doxorubicin—hematologic cancer	2.23e-05	0.000103	CcSEcCtD
Nabilone—Asthenia—Prednisone—hematologic cancer	2.22e-05	0.000102	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—HRAS—hematologic cancer	2.22e-05	0.00031	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CCL2—hematologic cancer	2.22e-05	0.000309	CbGpPWpGaD
Nabilone—Pain—Methotrexate—hematologic cancer	2.21e-05	0.000102	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—IL6R—hematologic cancer	2.21e-05	0.000308	CbGpPWpGaD
Nabilone—Musculoskeletal discomfort—Epirubicin—hematologic cancer	2.21e-05	0.000102	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—CREBBP—hematologic cancer	2.21e-05	0.000308	CbGpPWpGaD
Nabilone—Shock—Doxorubicin—hematologic cancer	2.21e-05	0.000102	CcSEcCtD
Nabilone—Pruritus—Prednisone—hematologic cancer	2.19e-05	0.000101	CcSEcCtD
Nabilone—Insomnia—Epirubicin—hematologic cancer	2.19e-05	0.000101	CcSEcCtD
Nabilone—Tachycardia—Doxorubicin—hematologic cancer	2.19e-05	0.000101	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—CDKN1B—hematologic cancer	2.18e-05	0.000304	CbGpPWpGaD
Nabilone—Paraesthesia—Epirubicin—hematologic cancer	2.18e-05	0.0001	CcSEcCtD
Nabilone—Hyperhidrosis—Doxorubicin—hematologic cancer	2.17e-05	9.98e-05	CcSEcCtD
Nabilone—Dyspnoea—Epirubicin—hematologic cancer	2.16e-05	9.94e-05	CcSEcCtD
Nabilone—CNR2—GPCR downstream signaling—AKT1—hematologic cancer	2.16e-05	0.000301	CbGpPWpGaD
Nabilone—Somnolence—Epirubicin—hematologic cancer	2.15e-05	9.92e-05	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—CASP3—hematologic cancer	2.14e-05	0.000298	CbGpPWpGaD
Nabilone—Anorexia—Doxorubicin—hematologic cancer	2.14e-05	9.84e-05	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—IL2—hematologic cancer	2.14e-05	0.000298	CbGpPWpGaD
Nabilone—Feeling abnormal—Methotrexate—hematologic cancer	2.13e-05	9.82e-05	CcSEcCtD
Nabilone—Dyspepsia—Epirubicin—hematologic cancer	2.13e-05	9.82e-05	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—IL6—hematologic cancer	2.12e-05	0.000296	CbGpPWpGaD
Nabilone—Diarrhoea—Prednisone—hematologic cancer	2.12e-05	9.76e-05	CcSEcCtD
Nabilone—Gastrointestinal pain—Methotrexate—hematologic cancer	2.12e-05	9.75e-05	CcSEcCtD
Nabilone—Nausea—Dexamethasone—hematologic cancer	2.11e-05	9.73e-05	CcSEcCtD
Nabilone—Nausea—Betamethasone—hematologic cancer	2.11e-05	9.73e-05	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—MAP2K1—hematologic cancer	2.11e-05	0.000294	CbGpPWpGaD
Nabilone—Decreased appetite—Epirubicin—hematologic cancer	2.11e-05	9.7e-05	CcSEcCtD
Nabilone—Hypotension—Doxorubicin—hematologic cancer	2.1e-05	9.64e-05	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—PIK3CD—hematologic cancer	2.09e-05	0.000292	CbGpPWpGaD
Nabilone—Fatigue—Epirubicin—hematologic cancer	2.09e-05	9.62e-05	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—CCND1—hematologic cancer	2.08e-05	0.00029	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—JUN—hematologic cancer	2.08e-05	0.00029	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—PIK3CA—hematologic cancer	2.07e-05	0.000289	CbGpPWpGaD
Nabilone—Constipation—Epirubicin—hematologic cancer	2.07e-05	9.54e-05	CcSEcCtD
Nabilone—Pain—Epirubicin—hematologic cancer	2.07e-05	9.54e-05	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—KRAS—hematologic cancer	2.05e-05	0.000286	CbGpPWpGaD
Nabilone—Dizziness—Prednisone—hematologic cancer	2.05e-05	9.43e-05	CcSEcCtD
Nabilone—Body temperature increased—Methotrexate—hematologic cancer	2.05e-05	9.42e-05	CcSEcCtD
Nabilone—Abdominal pain—Methotrexate—hematologic cancer	2.05e-05	9.42e-05	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	2.04e-05	9.4e-05	CcSEcCtD
Nabilone—Insomnia—Doxorubicin—hematologic cancer	2.03e-05	9.34e-05	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—CDKN1A—hematologic cancer	2.01e-05	0.000281	CbGpPWpGaD
Nabilone—Paraesthesia—Doxorubicin—hematologic cancer	2.01e-05	9.27e-05	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—PTEN—hematologic cancer	2.01e-05	0.00028	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—FGF2—hematologic cancer	2e-05	0.000279	CbGpPWpGaD
Nabilone—Dyspnoea—Doxorubicin—hematologic cancer	2e-05	9.2e-05	CcSEcCtD
Nabilone—Feeling abnormal—Epirubicin—hematologic cancer	2e-05	9.19e-05	CcSEcCtD
Nabilone—Somnolence—Doxorubicin—hematologic cancer	1.99e-05	9.18e-05	CcSEcCtD
Nabilone—Gastrointestinal pain—Epirubicin—hematologic cancer	1.98e-05	9.12e-05	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—PIK3R1—hematologic cancer	1.98e-05	0.000276	CbGpPWpGaD
Nabilone—Dyspepsia—Doxorubicin—hematologic cancer	1.97e-05	9.09e-05	CcSEcCtD
Nabilone—Vomiting—Prednisone—hematologic cancer	1.97e-05	9.07e-05	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—MAPK8—hematologic cancer	1.97e-05	0.000274	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—AKT1—hematologic cancer	1.96e-05	0.000273	CbGpPWpGaD
Nabilone—Rash—Prednisone—hematologic cancer	1.95e-05	8.99e-05	CcSEcCtD
Nabilone—Dermatitis—Prednisone—hematologic cancer	1.95e-05	8.98e-05	CcSEcCtD
Nabilone—Decreased appetite—Doxorubicin—hematologic cancer	1.95e-05	8.97e-05	CcSEcCtD
Nabilone—Headache—Prednisone—hematologic cancer	1.94e-05	8.93e-05	CcSEcCtD
Nabilone—Fatigue—Doxorubicin—hematologic cancer	1.93e-05	8.9e-05	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—JAK2—hematologic cancer	1.92e-05	0.000268	CbGpPWpGaD
Nabilone—Pain—Doxorubicin—hematologic cancer	1.92e-05	8.83e-05	CcSEcCtD
Nabilone—Constipation—Doxorubicin—hematologic cancer	1.92e-05	8.83e-05	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—EP300—hematologic cancer	1.92e-05	0.000267	CbGpPWpGaD
Nabilone—Abdominal pain—Epirubicin—hematologic cancer	1.92e-05	8.82e-05	CcSEcCtD
Nabilone—Body temperature increased—Epirubicin—hematologic cancer	1.92e-05	8.82e-05	CcSEcCtD
Nabilone—Hypersensitivity—Methotrexate—hematologic cancer	1.91e-05	8.78e-05	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—PIK3CA—hematologic cancer	1.88e-05	0.000263	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—MDM2—hematologic cancer	1.88e-05	0.000262	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—SRC—hematologic cancer	1.86e-05	0.00026	CbGpPWpGaD
Nabilone—Asthenia—Methotrexate—hematologic cancer	1.86e-05	8.55e-05	CcSEcCtD
Nabilone—Feeling abnormal—Doxorubicin—hematologic cancer	1.85e-05	8.51e-05	CcSEcCtD
Nabilone—Nausea—Prednisone—hematologic cancer	1.84e-05	8.47e-05	CcSEcCtD
Nabilone—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.83e-05	8.44e-05	CcSEcCtD
Nabilone—Pruritus—Methotrexate—hematologic cancer	1.83e-05	8.43e-05	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—MTOR—hematologic cancer	1.82e-05	0.000254	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PIK3CB—hematologic cancer	1.82e-05	0.000254	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—VEGFA—hematologic cancer	1.81e-05	0.000253	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—STAT3—hematologic cancer	1.8e-05	0.000251	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—NRAS—hematologic cancer	1.79e-05	0.00025	CbGpPWpGaD
Nabilone—Hypersensitivity—Epirubicin—hematologic cancer	1.79e-05	8.22e-05	CcSEcCtD
Nabilone—Abdominal pain—Doxorubicin—hematologic cancer	1.77e-05	8.16e-05	CcSEcCtD
Nabilone—Body temperature increased—Doxorubicin—hematologic cancer	1.77e-05	8.16e-05	CcSEcCtD
Nabilone—Diarrhoea—Methotrexate—hematologic cancer	1.77e-05	8.16e-05	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—HRAS—hematologic cancer	1.74e-05	0.000243	CbGpPWpGaD
Nabilone—Asthenia—Epirubicin—hematologic cancer	1.74e-05	8e-05	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—MAPK3—hematologic cancer	1.72e-05	0.000239	CbGpPWpGaD
Nabilone—Pruritus—Epirubicin—hematologic cancer	1.71e-05	7.89e-05	CcSEcCtD
Nabilone—Dizziness—Methotrexate—hematologic cancer	1.71e-05	7.88e-05	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—CDKN1B—hematologic cancer	1.71e-05	0.000239	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—AKT1—hematologic cancer	1.69e-05	0.000236	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CASP3—hematologic cancer	1.68e-05	0.000234	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—IL2—hematologic cancer	1.68e-05	0.000234	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—MYC—hematologic cancer	1.67e-05	0.000233	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—IL6—hematologic cancer	1.67e-05	0.000232	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—TGFB1—hematologic cancer	1.67e-05	0.000232	CbGpPWpGaD
Nabilone—Diarrhoea—Epirubicin—hematologic cancer	1.66e-05	7.63e-05	CcSEcCtD
Nabilone—Hypersensitivity—Doxorubicin—hematologic cancer	1.65e-05	7.6e-05	CcSEcCtD
Nabilone—Vomiting—Methotrexate—hematologic cancer	1.65e-05	7.58e-05	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—CCND1—hematologic cancer	1.63e-05	0.000228	CbGpPWpGaD
Nabilone—Rash—Methotrexate—hematologic cancer	1.63e-05	7.52e-05	CcSEcCtD
Nabilone—Dermatitis—Methotrexate—hematologic cancer	1.63e-05	7.51e-05	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—JUN—hematologic cancer	1.63e-05	0.000227	CbGpPWpGaD
Nabilone—Headache—Methotrexate—hematologic cancer	1.62e-05	7.47e-05	CcSEcCtD
Nabilone—Asthenia—Doxorubicin—hematologic cancer	1.61e-05	7.41e-05	CcSEcCtD
Nabilone—Dizziness—Epirubicin—hematologic cancer	1.6e-05	7.38e-05	CcSEcCtD
Nabilone—Pruritus—Doxorubicin—hematologic cancer	1.59e-05	7.3e-05	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—CDKN1A—hematologic cancer	1.58e-05	0.00022	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PTEN—hematologic cancer	1.58e-05	0.00022	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—KRAS—hematologic cancer	1.54e-05	0.000215	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—MAPK8—hematologic cancer	1.54e-05	0.000215	CbGpPWpGaD
Nabilone—Vomiting—Epirubicin—hematologic cancer	1.54e-05	7.09e-05	CcSEcCtD
Nabilone—Nausea—Methotrexate—hematologic cancer	1.54e-05	7.08e-05	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—AKT1—hematologic cancer	1.54e-05	0.000214	CbGpPWpGaD
Nabilone—Diarrhoea—Doxorubicin—hematologic cancer	1.53e-05	7.06e-05	CcSEcCtD
Nabilone—Rash—Epirubicin—hematologic cancer	1.53e-05	7.03e-05	CcSEcCtD
Nabilone—Dermatitis—Epirubicin—hematologic cancer	1.53e-05	7.03e-05	CcSEcCtD
Nabilone—Headache—Epirubicin—hematologic cancer	1.52e-05	6.99e-05	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—EP300—hematologic cancer	1.5e-05	0.00021	CbGpPWpGaD
Nabilone—Dizziness—Doxorubicin—hematologic cancer	1.48e-05	6.83e-05	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—SRC—hematologic cancer	1.46e-05	0.000204	CbGpPWpGaD
Nabilone—Nausea—Epirubicin—hematologic cancer	1.44e-05	6.63e-05	CcSEcCtD
Nabilone—Vomiting—Doxorubicin—hematologic cancer	1.43e-05	6.56e-05	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—VEGFA—hematologic cancer	1.42e-05	0.000199	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PIK3CA—hematologic cancer	1.42e-05	0.000198	CbGpPWpGaD
Nabilone—Rash—Doxorubicin—hematologic cancer	1.41e-05	6.51e-05	CcSEcCtD
Nabilone—Dermatitis—Doxorubicin—hematologic cancer	1.41e-05	6.5e-05	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—STAT3—hematologic cancer	1.41e-05	0.000197	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—NRAS—hematologic cancer	1.41e-05	0.000196	CbGpPWpGaD
Nabilone—Headache—Doxorubicin—hematologic cancer	1.4e-05	6.47e-05	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—TP53—hematologic cancer	1.37e-05	0.000191	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—MAPK3—hematologic cancer	1.35e-05	0.000188	CbGpPWpGaD
Nabilone—Nausea—Doxorubicin—hematologic cancer	1.33e-05	6.13e-05	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—HRAS—hematologic cancer	1.31e-05	0.000183	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—MYC—hematologic cancer	1.31e-05	0.000183	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—TGFB1—hematologic cancer	1.31e-05	0.000182	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—IL6—hematologic cancer	1.26e-05	0.000175	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—KRAS—hematologic cancer	1.21e-05	0.000169	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—AKT1—hematologic cancer	1.16e-05	0.000161	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PIK3CA—hematologic cancer	1.11e-05	0.000155	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—TP53—hematologic cancer	1.08e-05	0.00015	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—HRAS—hematologic cancer	1.03e-05	0.000143	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—IL6—hematologic cancer	9.85e-06	0.000137	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—AKT1—hematologic cancer	9.09e-06	0.000127	CbGpPWpGaD
